Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2003 1
2004 1
2005 2
2006 1
2010 1
2011 1
2012 1
2020 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Downstream insulin-like growth factor.
Pfäffle R, Kiess W, Klammt J. Pfäffle R, et al. Endocr Dev. 2012;23:42-51. doi: 10.1159/000341745. Epub 2012 Nov 23. Endocr Dev. 2012. PMID: 23182819 Review.
With the first descriptions of patients born small for gestational age carrying mutations within the insulin-like growth factor type 1 receptor (IGF-1R) gene, genetic defects at the lower end of the GH-IGF-1 axis were identified as …
With the first descriptions of patients born small for gestational age carrying mutations within the insulin-like growth
Update on methods to enhance growth.
Hodax JK, DiVall SA. Hodax JK, et al. Curr Opin Endocrinol Diabetes Obes. 2020 Feb;27(1):82-86. doi: 10.1097/MED.0000000000000513. Curr Opin Endocrinol Diabetes Obes. 2020. PMID: 31789832 Review.
PURPOSE OF REVIEW: To discuss treatments used to enhance growth in pediatric patients with short stature. RECENT FINDINGS: New data confirm the known efficacy of recombinant human growth hormone (rhGH) in growth hormone deficiency (GHD) and idiopathic …
PURPOSE OF REVIEW: To discuss treatments used to enhance growth in pediatric patients with short stature. RECENT FINDINGS: New data c …
Progress on growth promoting therapies other than growth hormone.
Xue C, Fu J. Xue C, et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Aug 1;51(4):515-520. doi: 10.3724/zdxbyxb-2022-0099. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 37202099 Free PMC article. Review. English.
Recombinant human insulin-like growth factor (IGF)-1 is the main treatment for primary IGF-1 deficiency, and C-type natriuretic peptide (CNP) offers a therapeutic option for children with short stature due to chondrodysplasi …
Recombinant human insulin-like growth factor (IGF)-1 is the main treatment for primary IGF-1 de
Insulin-like growth factor 1 (IGF-1) and aging: controversies and new insights.
Bartke A, Chandrashekar V, Dominici F, Turyn D, Kinney B, Steger R, Kopchick JJ. Bartke A, et al. Biogerontology. 2003;4(1):1-8. doi: 10.1023/a:1022448532248. Biogerontology. 2003. PMID: 12652183 Review.
Insulin/insulin-like growth factor (IGF) signaling plays a major role in the control of aging and life span in invertebrates. Major extension of life span in growth hormone receptor knock out (GHR-KO) mice that are GH resistant, and subse
Insulin/insulin-like growth factor (IGF) signaling plays a major role in the control of aging and life sp
Growth hormone, insulin and aging: the benefits of endocrine defects.
Bartke A. Bartke A. Exp Gerontol. 2011 Feb-Mar;46(2-3):108-11. doi: 10.1016/j.exger.2010.08.020. Epub 2010 Sep 17. Exp Gerontol. 2011. PMID: 20851173 Free PMC article. Review.
Longevity of mice can be increased by spontaneous or experimentally induced mutations that interfere with the biosynthesis or actions of growth hormone (GH), insulin-like growth factor 1 (IGF-1), or insulin in the adipose ti …
Longevity of mice can be increased by spontaneous or experimentally induced mutations that interfere with the biosynthesis or actions of …
Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
[No authors listed] [No authors listed] Drugs R D. 2005;6(2):120-7. doi: 10.2165/00126839-200506020-00008. Drugs R D. 2005. PMID: 15777106 Review.
Insmed is developing mecasermin rinfabate, a recombinant complex of insulin-like growth factor-I (rhIGF-I) and binding protein-3 (rhIGFBP-3) [insulin-like growth factor-I/insulin-like growth factor
Insmed is developing mecasermin rinfabate, a recombinant complex of insulin-like growth factor-I (rhIGF-I) and b …
Growth and sexual maturation in children with insulin-dependent diabetes mellitus.
Malone JI. Malone JI. Curr Opin Pediatr. 1993 Aug;5(4):494-8. doi: 10.1097/00008480-199308000-00021. Curr Opin Pediatr. 1993. PMID: 8374679 Review.
The normal release of growth hormone and the hepatic production of insulin-like growth factor I is modulated by the action of insulin. The absence of physiologic insulin response leads to dysfunctional quantities of growth h …
The normal release of growth hormone and the hepatic production of insulin-like growth factor I is modula …
Pituitary Dysfunction Following Snakebite Envenomation: A Clinico-Radiological Assessment of 15 Cases and Review of the Literature.
Roy A, Suryadevara V, Nagarajan K, Sahoo J, Naik D, Perumal NL, Narayanan N, Merugu C, Patel D, Patil M, Kamalanathan S. Roy A, et al. Neurol India. 2022 Sep-Oct;70(5):2093-2099. doi: 10.4103/0028-3886.359201. Neurol India. 2022. PMID: 36352614 Free article. Review.
The study was a record-based retrospective analysis of the patients with HP following SE. Clinical data including lag time in diagnosis and type of snake were determined. Further, hormonal data including all the anterior pituitary functions (thyroid stimulating hormone, fr …
The study was a record-based retrospective analysis of the patients with HP following SE. Clinical data including lag time in diagnosis and …
Life extension in the dwarf mouse.
Bartke A, Brown-Borg H. Bartke A, et al. Curr Top Dev Biol. 2004;63:189-225. doi: 10.1016/S0070-2153(04)63006-7. Curr Top Dev Biol. 2004. PMID: 15536017 Review.
We propose that mechanisms linking GH deficiency and GH resistance with delayed aging include reduced hepatic synthesis of insulin-like growth factor 1 (IGF-1), reduced secretion of insulin, increased hepatic sensitiv …
We propose that mechanisms linking GH deficiency and GH resistance with delayed aging include reduced hepatic synthesis of …
Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults.
Yuen KC, Dunger DB. Yuen KC, et al. Growth Horm IGF Res. 2006 Jul;16 Suppl A:S55-61. doi: 10.1016/j.ghir.2006.03.001. Epub 2006 Apr 18. Growth Horm IGF Res. 2006. PMID: 16624605 Review.
Supraphysiological doses of growth hormone (GH) therapy are generally thought to antagonize the effects of insulin, whereas the insulin-like growth factor I (IGF-I) potentiates insulin-like actions. ...Growth hormone …
Supraphysiological doses of growth hormone (GH) therapy are generally thought to antagonize the effects of insulin, whereas th …
11 results